Jfr Robertson

发表

The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome

S. Pinder, I. Ellis, Sy Chan, 2004, The Journal of pathology.

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.

I. Ellis, R. Blamey, R. Nicholson, 1995, British Journal of Cancer.

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

I. Ellis, R. Blamey, R. Nicholson, 1998, Oncogene.

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

I. Ellis, R. Blamey, R. Nicholson, 2004, British Journal of Cancer.

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts.

I. Ellis, J. Robertson, I. Ellis, 1999 .

Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.

I. Ellis, J. Robertson, R. Blamey, 1998, British Journal of Cancer.

Thymidine kinase in breast cancer.

R. Blamey, J. Robertson, K. O’Neill, 1990, British Journal of Cancer.

Failure of CA19-9 to detect asymptomatic colorectal carcinoma.

J. Robertson, M. Price, J. Hardcastle, 1991, British Journal of Cancer.